Literature DB >> 15545863

Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.

Paul M Mendelman1, Ruth Rappaport, Iksung Cho, Stan Block, William Gruber, Marilyn August, Denise Dawson, Julie Cordova, George Kemble, Kutubuddin Mahmood, Giuseppe Palladino, Min-Shi Lee, Ahmad Razmpour, Jeffrey Stoddard, Bruce D Forrest.   

Abstract

Serum antibody titers against the A/Panama/2007/99(H3N2) and A/Fujian/411/2002(H3N2)-like viruses were determined in children 6-35 months of age who received either 1 dose of the inactivated influenza vaccine or the live attenuated influenza vaccine containing the A/Panama strain. Results indicated that the live vaccine induced higher antibody responses than the inactivated vaccine against the A/Panama and A/Fujian-like viruses.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15545863     DOI： 10.1097/01.inf.0000143643.44463.b1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  18 in total

1.  Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects.

Authors:  Stan L Block; Keith S Reisinger; Micki Hultquist; Robert E Walker
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

2.  A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

Authors:  Kawsar R Talaat; Catherine J Luke; Surender Khurana; Jody Manischewitz; Lisa R King; Bridget A McMahon; Ruth A Karron; Kristen D C Lewis; Jing Qin; Dean A Follmann; Hana Golding; Kathleen M Neuzil; Kanta Subbarao
Journal:  J Infect Dis       Date:  2014-03-05       Impact factor: 5.226

3.  Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

Authors:  Sanae Sasaki; Maria C Jaimes; Tyson H Holmes; Cornelia L Dekker; Kutubuddin Mahmood; George W Kemble; Ann M Arvin; Harry B Greenberg
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

4.  Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.

Authors:  Sinthujan Jegaskanda; Rosemarie D Mason; Sarah F Andrews; Adam K Wheatley; Ruijun Zhang; Glennys V Reynoso; David R Ambrozak; Celia P Santos; Catherine J Luke; Yumiko Matsuoka; Jason M Brenchley; Heather D Hickman; Kawsar R Talaat; Sallie R Permar; Hua-Xin Liao; Jonathan W Yewdell; Richard A Koup; Mario Roederer; Adrian B McDermott; Kanta Subbarao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Authors:  Yumiko Matsuoka; Amorsolo Suguitan; Marlene Orandle; Myeisha Paskel; Kobporn Boonnak; Donald J Gardner; Friederike Feldmann; Heinz Feldmann; Michael Marino; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

6.  Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Authors:  Bruce D Forrest; Michael W Pride; Andrew J Dunning; Maria Rosario Z Capeding; Tawee Chotpitayasunondh; John S Tam; Ruth Rappaport; John H Eldridge; William C Gruber
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

Review 7.  Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Authors:  Michael Schotsaert; Marina De Filette; Walter Fiers; Xavier Saelens
Journal:  Expert Rev Vaccines       Date:  2009-04       Impact factor: 5.217

8.  Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Authors:  Ruth A Karron; Kawsar Talaat; Catherine Luke; Karen Callahan; Bhagvanji Thumar; Susan Dilorenzo; Josephine McAuliffe; Elizabeth Schappell; Amorsolo Suguitan; Kimberly Mills; Grace Chen; Elaine Lamirande; Kathleen Coelingh; Hong Jin; Brian R Murphy; George Kemble; Kanta Subbarao
Journal:  Vaccine       Date:  2009-06-21       Impact factor: 3.641

9.  A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Authors:  Kawsar R Talaat; Ruth A Karron; Karen A Callahan; Catherine J Luke; Susan C DiLorenzo; Grace L Chen; Elaine W Lamirande; Hong Jin; Kathy L Coelingh; Brian R Murphy; George Kemble; Kanta Subbarao
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

10.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.